Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	extracellular matrix	COL4A3 COL4A6 HSPG2 LINGO3 MATN4 MUC5B SNED1 HMCN2 HMCN1 MEGF6 OTOGL PLG USH2A	9.39e-06	656	96	13	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL4A3 COL4A6 HSPG2 LINGO3 MATN4 MUC5B SNED1 HMCN2 HMCN1 MEGF6 OTOGL PLG USH2A	9.70e-06	658	96	13	GO:0030312
GeneOntologyCellularComponent	basement membrane	COL4A3 COL4A6 HSPG2 HMCN2 HMCN1 USH2A	2.11e-05	122	96	6	GO:0005604
GeneOntologyCellularComponent	collagen type IV trimer	COL4A3 COL4A6	3.09e-04	6	96	2	GO:0005587
GeneOntologyCellularComponent	synaptic membrane	SEMA4F SCN11A IL31RA LHFPL4 GRIK5 DNAJC6 RGS7 GRIN3A MUSK SEZ6L	3.46e-04	583	96	10	GO:0097060
GeneOntologyCellularComponent	heteromeric SMAD protein complex	SMAD2 SMAD9	5.74e-04	8	96	2	GO:0071144
GeneOntologyCellularComponent	basement membrane collagen trimer	COL4A3 COL4A6	5.74e-04	8	96	2	GO:0098651
GeneOntologyCellularComponent	network-forming collagen trimer	COL4A3 COL4A6	5.74e-04	8	96	2	GO:0098642
GeneOntologyCellularComponent	collagen network	COL4A3 COL4A6	5.74e-04	8	96	2	GO:0098645
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COL4A3 COL4A6 HSPG2 MATN4 HMCN2 HMCN1 MEGF6 PLG USH2A	7.43e-04	530	96	9	GO:0062023
GeneOntologyCellularComponent	SMAD protein complex	SMAD2 SMAD9	9.17e-04	10	96	2	GO:0071141
GeneOntologyCellularComponent	receptor complex	SEMA4D IL31RA GRIK5 TEK CR2 TYRO3 EBI3 GRIN3A MUSK	1.41e-03	581	96	9	GO:0043235
Domain	Ig-like_fold	PAPPA2 SEMA4D HSPG2 IGFN1 IL31RA LINGO3 MDGA2 TEK TYRO3 SNED1 HMCN2 HMCN1 PTPRJ EBI3 SIGIRR SIGLEC6 PVR IGSF9 USH2A MUSK	2.65e-10	706	94	20	IPR013783
Domain	-	PAPPA2 SEMA4D HSPG2 IGFN1 IL31RA LINGO3 MDGA2 TEK TYRO3 SNED1 HMCN1 PTPRJ EBI3 SIGIRR SIGLEC6 PVR IGSF9 USH2A MUSK	6.56e-10	663	94	19	2.60.40.10
Domain	FN3_dom	PAPPA2 IGFN1 IL31RA MDGA2 TEK TYRO3 SNED1 PTPRJ EBI3 IGSF9 USH2A	8.12e-09	209	94	11	IPR003961
Domain	IGc2	SEMA4D HSPG2 IGFN1 LINGO3 MDGA2 TYRO3 HMCN2 HMCN1 SIGLEC6 IGSF9 MUSK	2.73e-08	235	94	11	SM00408
Domain	Ig_sub2	SEMA4D HSPG2 IGFN1 LINGO3 MDGA2 TYRO3 HMCN2 HMCN1 SIGLEC6 IGSF9 MUSK	2.73e-08	235	94	11	IPR003598
Domain	FN3	PAPPA2 IGFN1 IL31RA TEK TYRO3 SNED1 PTPRJ EBI3 IGSF9 USH2A	3.14e-08	185	94	10	SM00060
Domain	Ig_I-set	HSPG2 IGFN1 LINGO3 MDGA2 TYRO3 HMCN2 HMCN1 SIGLEC6 IGSF9 MUSK	4.04e-08	190	94	10	IPR013098
Domain	I-set	HSPG2 IGFN1 LINGO3 MDGA2 TYRO3 HMCN2 HMCN1 SIGLEC6 IGSF9 MUSK	4.04e-08	190	94	10	PF07679
Domain	FN3	IGFN1 IL31RA MDGA2 TEK TYRO3 SNED1 PTPRJ EBI3 IGSF9 USH2A	6.25e-08	199	94	10	PS50853
Domain	fn3	IGFN1 IL31RA TEK TYRO3 SNED1 PTPRJ EBI3 IGSF9 USH2A	1.26e-07	162	94	9	PF00041
Domain	IG_LIKE	SEMA4D HSPG2 IGFN1 LINGO3 MDGA2 TEK TYRO3 HMCN2 HMCN1 SIGIRR SIGLEC6 PVR IGSF9 MUSK	1.59e-07	491	94	14	PS50835
Domain	Ig-like_dom	SEMA4D HSPG2 IGFN1 LINGO3 MDGA2 TEK TYRO3 HMCN2 HMCN1 SIGIRR SIGLEC6 PVR IGSF9 MUSK	2.14e-07	503	94	14	IPR007110
Domain	CCP	SELP PAPPA2 CR2 SNED1 CSMD1 SEZ6L	2.94e-07	54	94	6	SM00032
Domain	SUSHI	SELP PAPPA2 CR2 SNED1 CSMD1 SEZ6L	3.67e-07	56	94	6	PS50923
Domain	Sushi_SCR_CCP_dom	SELP PAPPA2 CR2 SNED1 CSMD1 SEZ6L	4.08e-07	57	94	6	IPR000436
Domain	IG	SEMA4D HSPG2 IGFN1 LINGO3 MDGA2 TYRO3 HMCN2 HMCN1 SIGLEC6 PVR IGSF9 MUSK	1.33e-06	421	94	12	SM00409
Domain	Ig_sub	SEMA4D HSPG2 IGFN1 LINGO3 MDGA2 TYRO3 HMCN2 HMCN1 SIGLEC6 PVR IGSF9 MUSK	1.33e-06	421	94	12	IPR003599
Domain	EGF_1	SELP HSPG2 MATN4 TEK SNED1 HMCN2 HMCN1 MEGF6 USH2A	5.54e-06	255	94	9	PS00022
Domain	Sushi	SELP PAPPA2 CR2 CSMD1 SEZ6L	6.25e-06	52	94	5	PF00084
Domain	Growth_fac_rcpt_	HSPG2 MATN4 TEK HMCN2 HMCN1 MEGF6 ELAPOR1	1.38e-05	156	94	7	IPR009030
Domain	EGF_3	SELP HSPG2 MATN4 TEK SNED1 HMCN2 HMCN1 MEGF6	2.45e-05	235	94	8	PS50026
Domain	EGF_CA	HSPG2 MATN4 SNED1 HMCN2 HMCN1 MEGF6	3.50e-05	122	94	6	SM00179
Domain	EGF-like_dom	SELP HSPG2 MATN4 TEK SNED1 HMCN2 HMCN1 MEGF6	3.70e-05	249	94	8	IPR000742
Domain	EGF-like_Ca-bd_dom	HSPG2 MATN4 SNED1 HMCN2 HMCN1 MEGF6	3.83e-05	124	94	6	IPR001881
Domain	EGF	SELP HSPG2 MATN4 SNED1 HMCN1 MEGF6	4.19e-05	126	94	6	PF00008
Domain	ig	SEMA4D HSPG2 MDGA2 TYRO3 HMCN1 SIGLEC6 PVR	4.90e-05	190	94	7	PF00047
Domain	Immunoglobulin	SEMA4D HSPG2 MDGA2 TYRO3 HMCN1 SIGLEC6 PVR	4.90e-05	190	94	7	IPR013151
Domain	EGF-like_CS	SELP HSPG2 MATN4 TEK SNED1 HMCN2 HMCN1 MEGF6	5.16e-05	261	94	8	IPR013032
Domain	EGF_2	SELP HSPG2 MATN4 TEK SNED1 HMCN2 HMCN1 MEGF6	5.74e-05	265	94	8	PS01186
Domain	LamGL	PAPPA2 USH2A	1.49e-04	4	94	2	SM00560
Domain	GFP	HMCN2 HMCN1	1.49e-04	4	94	2	IPR009017
Domain	G2F	HMCN2 HMCN1	1.49e-04	4	94	2	PF07474
Domain	LamG-like	PAPPA2 USH2A	1.49e-04	4	94	2	IPR006558
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	1.49e-04	4	94	2	IPR006605
Domain	NIDOGEN_G2	HMCN2 HMCN1	1.49e-04	4	94	2	PS50993
Domain	ASX_HYDROXYL	MATN4 SNED1 HMCN2 HMCN1 MEGF6	1.50e-04	100	94	5	PS00010
Domain	EGF	SELP HSPG2 MATN4 TEK SNED1 HMCN1 MEGF6	1.85e-04	235	94	7	SM00181
Domain	EGF-type_Asp/Asn_hydroxyl_site	MATN4 SNED1 HMCN2 HMCN1 MEGF6	1.97e-04	106	94	5	IPR000152
Domain	C4	COL4A3 COL4A6	3.71e-04	6	94	2	SM00111
Domain	-	COL4A3 COL4A6	3.71e-04	6	94	2	2.170.240.10
Domain	Collagen_VI_NC	COL4A3 COL4A6	3.71e-04	6	94	2	IPR001442
Domain	C4	COL4A3 COL4A6	3.71e-04	6	94	2	PF01413
Domain	NC1_IV	COL4A3 COL4A6	3.71e-04	6	94	2	PS51403
Domain	Dwarfin	SMAD2 SMAD9	6.88e-04	8	94	2	IPR013790
Domain	DWB	SMAD2 SMAD9	6.88e-04	8	94	2	SM00524
Domain	MH2	SMAD2 SMAD9	6.88e-04	8	94	2	PS51076
Domain	MH1	SMAD2 SMAD9	6.88e-04	8	94	2	PS51075
Domain	-	SMAD2 SMAD9	6.88e-04	8	94	2	3.90.520.10
Domain	MAD_homology_MH1	SMAD2 SMAD9	6.88e-04	8	94	2	IPR013019
Domain	MH2	SMAD2 SMAD9	6.88e-04	8	94	2	PF03166
Domain	SMAD_dom_Dwarfin-type	SMAD2 SMAD9	6.88e-04	8	94	2	IPR001132
Domain	Laminin_EGF	HSPG2 MEGF6 USH2A	7.19e-04	35	94	3	PF00053
Domain	EGF_Lam	HSPG2 MEGF6 USH2A	7.19e-04	35	94	3	SM00180
Domain	Laminin_EGF	HSPG2 MEGF6 USH2A	9.17e-04	38	94	3	IPR002049
Domain	EGF_CA	MATN4 HMCN2 HMCN1 MEGF6	9.32e-04	86	94	4	PF07645
Domain	Peripla_BP_I	GRIK5 GUCY2C GRIN3A	9.89e-04	39	94	3	IPR028082
Domain	EGF_Ca-bd_CS	SNED1 HMCN2 HMCN1 MEGF6	1.46e-03	97	94	4	IPR018097
Domain	EGF_CA	SNED1 HMCN2 HMCN1 MEGF6	1.57e-03	99	94	4	PS01187
Domain	MAD_homology1_Dwarfin-type	SMAD2 SMAD9	1.60e-03	12	94	2	IPR003619
Domain	DWA	SMAD2 SMAD9	1.60e-03	12	94	2	SM00523
Domain	MH1	SMAD2 SMAD9	1.60e-03	12	94	2	PF03165
Domain	Kelch_2	KLHDC2 KLHL31	1.89e-03	13	94	2	IPR011498
Domain	Kelch_2	KLHDC2 KLHL31	1.89e-03	13	94	2	PF07646
Domain	SMAD_FHA_domain	STARD9 SMAD2 SMAD9	2.28e-03	52	94	3	IPR008984
Domain	SMAD_dom-like	SMAD2 SMAD9	2.87e-03	16	94	2	IPR017855
Domain	-	SMAD2 SMAD9	2.87e-03	16	94	2	2.60.200.10
Domain	Iontro_rcpt	GRIK5 GRIN3A	3.64e-03	18	94	2	IPR001320
Domain	Lig_chan-Glu_bd	GRIK5 GRIN3A	3.64e-03	18	94	2	PF10613
Domain	Iono_rcpt_met	GRIK5 GRIN3A	3.64e-03	18	94	2	IPR001508
Domain	Glu/Gly-bd	GRIK5 GRIN3A	3.64e-03	18	94	2	IPR019594
Domain	Lig_chan-Glu_bd	GRIK5 GRIN3A	3.64e-03	18	94	2	SM00918
Domain	Lig_chan	GRIK5 GRIN3A	3.64e-03	18	94	2	PF00060
Domain	PBPe	GRIK5 GRIN3A	3.64e-03	18	94	2	SM00079
Domain	Pkinase_Tyr	TEK TYRO3 GUCY2C MUSK	4.10e-03	129	94	4	PF07714
Domain	Semaphorin	SEMA4F SEMA4D	4.49e-03	20	94	2	IPR027231
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL4A3 COL4A6 HSPG2 MATN4 MUSK	2.76e-05	76	66	5	M27219
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A3 COL4A6 PLG	3.44e-05	14	66	3	MM1458
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A3 COL4A6 PLG	3.44e-05	14	66	3	M6487
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A3 COL4A6 MEGF6	4.28e-05	15	66	3	MM14922
Pathway	BIOCARTA_AMI_PATHWAY	COL4A3 COL4A6 PLG	1.06e-04	20	66	3	M15394
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A3 COL4A6 HSPG2	3.64e-04	30	66	3	M27216
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL4A3 COL4A6 HSPG2 HMCN2 HMCN1 MEGF6 PLG	6.81e-07	175	98	7	28071719
Pubmed	Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.	COL4A3 COL4A6 HSPG2	2.57e-06	10	98	3	9136074
Pubmed	Binding of mouse and human fibulin-2 to extracellular matrix ligands.	COL4A3 COL4A6 HSPG2	3.52e-06	11	98	3	7500359
Pubmed	Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice.	COL4A3 COL4A6 HSPG2	4.69e-06	12	98	3	16024816
Pubmed	Spatiotemporal disorder in the axial skeleton development of the Mesp2-null mouse: a model of spondylocostal dysostosis and spondylothoracic dysostosis.	MESP2 SMAD2 SMAD9	7.72e-06	14	98	3	23238123
Pubmed	Rethinking isolated cleft lip and palate as a syndrome.	HMCN1 IGSF9	7.86e-06	2	98	2	29500156
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	7.86e-06	2	98	2	32035013
Pubmed	Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.	PAPPA2 SIGLEC6	7.86e-06	2	98	2	18818296
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL4A6 HSPG2 MATN4 HMCN2 HMCN1 PLG	8.18e-06	167	98	6	22159717
Pubmed	Identification of a novel cell-adhesive protein spatiotemporally expressed in the basement membrane of mouse developing hair follicle.	COL4A3 COL4A6 HSPG2	1.18e-05	16	98	3	15878328
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SEMA4D IL17REL RHBDF2 FRMPD1 TMPRSS5 NEK9 AHDC1 MEGF6 PTPRJ SIGIRR PVR PRKCE IGSF9 PISD CSMD1	1.79e-05	1489	98	15	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRMPD1 DNAJC6 ZNF365 USP31 LGI2 STARD9 ASB1 SEZ6L	2.06e-05	407	98	8	12693553
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	SEMA4F SEMA4D TMPRSS5 PVR IGSF9	2.09e-05	117	98	5	17145500
Pubmed	Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.	HMCN2 HMCN1	2.35e-05	3	98	2	12388743
Pubmed	A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure.	COL4A3 USH2A	2.35e-05	3	98	2	14676276
Pubmed	COL4A6 is dispensable for autosomal recessive Alport syndrome.	COL4A3 COL4A6	2.35e-05	3	98	2	27377778
Pubmed	Hemicentins assemble on diverse epithelia in the mouse.	HMCN2 HMCN1	2.35e-05	3	98	2	17015624
Pubmed	PITPNC1 Suppress CD8+ T cell immune function and promote radioresistance in rectal cancer by modulating FASN/CD155.	FASN PVR	2.35e-05	3	98	2	38291470
Pubmed	Endoglin Regulation of Smad2 Function Mediates Beclin1 Expression and Endothelial Autophagy.	AMBRA1 SMAD2	2.35e-05	3	98	2	25931117
Pubmed	Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation.	INHBA SMAD2	2.35e-05	3	98	2	28781074
Pubmed	A secreted protein promotes cleavage furrow maturation during cytokinesis.	HMCN2 HMCN1	2.35e-05	3	98	2	21215633
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KDM5B ARHGEF28 KLHDC2 ERCC6L NEK9 USP31 STARD9 RAB11FIP5 PRKCE PLEKHA7 MUSK	3.18e-05	861	98	11	36931259
Pubmed	Genetic susceptibility to chronic otitis media with effusion: candidate gene single nucleotide polymorphisms.	MUC5B SMAD2	4.70e-05	4	98	2	23929584
Pubmed	Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes.	INHBA SMAD2	4.70e-05	4	98	2	19517569
Pubmed	Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2.	HMCN2 HMCN1	4.70e-05	4	98	2	36007682
Pubmed	Activin signals via SMAD2/3 between germ and somatic cells in the human fetal ovary and regulates kit ligand expression.	INHBA SMAD2	4.70e-05	4	98	2	18166170
Pubmed	Semaphorin-plexin signalling genes associated with human breast tumourigenesis.	SEMA4F SEMA4D	4.70e-05	4	98	2	21925246
Pubmed	Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response.	INHBA SMAD2	4.70e-05	4	98	2	17478422
Pubmed	IL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infection.	IL31RA CR2	4.70e-05	4	98	2	19414760
Pubmed	SMAD2 and SMAD3 differentially regulate adiposity and the growth of subcutaneous white adipose tissue.	INHBA SMAD2	4.70e-05	4	98	2	34731499
Pubmed	Hemicentin-1 is an essential extracellular matrix component of the dermal-epidermal and myotendinous junctions.	HMCN2 HMCN1	4.70e-05	4	98	2	34504132
Pubmed	Brightfield proximity ligation assay reveals both canonical and mixed transforming growth factor-β/bone morphogenetic protein Smad signaling complexes in tissue sections.	SMAD2 SMAD9	7.82e-05	5	98	2	25141865
Pubmed	Complement-dependent P-selectin expression and injury following ischemic stroke.	SELP CR2	7.82e-05	5	98	2	17082645
Pubmed	Genome-wide association study of lung function decline in adults with and without asthma.	PRKCE CSMD1 MUSK	1.01e-04	32	98	3	22424883
Pubmed	Stimulation of extracellular matrix components in the normal brain by invading glioma cells.	COL4A3 COL4A6	1.17e-04	6	98	2	9506531
Pubmed	Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium.	SMAD2 SMAD9	1.17e-04	6	98	2	9256479
Pubmed	Smad7 is required for the development and function of the heart.	SMAD2 SMAD9	1.17e-04	6	98	2	18952608
Pubmed	Extracellular matrix of the human optic nerve head.	COL4A3 COL4A6	1.17e-04	6	98	2	2426947
Pubmed	Angiogenesis and collagen type IV expression in different endothelial cell culture systems.	COL4A3 COL4A6	1.17e-04	6	98	2	23551189
Pubmed	Monoclonal antibody to human basement membrane collagen type IV.	COL4A3 COL4A6	1.17e-04	6	98	2	6811420
Pubmed	Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas.	COL4A3 COL4A6	1.17e-04	6	98	2	6389236
Pubmed	Collagen IV in the developing lens capsule.	COL4A3 COL4A6	1.17e-04	6	98	2	12225806
Pubmed	Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome.	COL4A3 COL4A6	1.17e-04	6	98	2	10534397
Pubmed	The role of effectors of the activin signalling pathway, activin receptors IIA and IIB, and Smad2, in patterning of tooth development.	INHBA SMAD2	1.17e-04	6	98	2	11714685
Pubmed	Defective pulmonary vascular remodeling in Smad8 mutant mice.	SMAD2 SMAD9	1.17e-04	6	98	2	19419974
Pubmed	Regeneration of axons in injured spinal cord by activation of bone morphogenetic protein/Smad1 signaling pathway in adult neurons.	SMAD2 SMAD9	1.17e-04	6	98	2	21518886
Pubmed	A tumor derived motility factor that stimulates cell migration on extracellular matrix.	COL4A3 COL4A6	1.17e-04	6	98	2	9673377
Pubmed	Platelet P-selectin expression: requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-kinase.	SELP PRKCE	1.17e-04	6	98	2	12783114
Pubmed	Dynamic regulation of Smad expression during mesenchyme to epithelium transition in the metanephric kidney.	SMAD2 SMAD9	1.17e-04	6	98	2	11850197
Pubmed	Localization of type IV collagen a 1 to a 6 chains in basement membrane during mouse molar germ development.	COL4A3 COL4A6	1.17e-04	6	98	2	11732842
Pubmed	Developmental distribution of collagen IV isoforms and relevance to ocular diseases.	COL4A3 COL4A6	1.17e-04	6	98	2	19275937
Pubmed	Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin.	COL4A3 COL4A6	1.17e-04	6	98	2	6988303
Pubmed	Activin regulates estrogen receptor gene expression in the mouse ovary.	INHBA SMAD2	1.17e-04	6	98	2	17951260
Pubmed	Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.	SMAD2 SMAD9	1.64e-04	7	98	2	15009097
Pubmed	Interstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M.	COL4A3 COL4A6	1.64e-04	7	98	2	11711546
Pubmed	Endogenous inhibins regulate steroidogenesis in mouse TM3 Leydig cells by altering SMAD2 signalling.	INHBA SMAD2	1.64e-04	7	98	2	27465829
Pubmed	Regulation of protease nexin-1 target protease specificity by collagen type IV.	COL4A3 COL4A6	1.64e-04	7	98	2	8006028
Pubmed	Advances in the understanding of skeletal muscle weakness in murine models of diseases affecting nerve-evoked muscle activity, motor neurons, synapses and myofibers.	HSPG2 MUSK	1.64e-04	7	98	2	25042397
Pubmed	Corneal cell proteins and ocular surface pathology.	COL4A3 COL4A6	1.64e-04	7	98	2	10416788
Pubmed	Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface.	COL4A3 COL4A6	1.64e-04	7	98	2	1724753
Pubmed	Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction.	SMAD2 SMAD9	1.64e-04	7	98	2	15376321
Pubmed	Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals.	COL4A3 COL4A6	1.64e-04	7	98	2	17418794
Pubmed	Negative regulation of BMP/Smad signaling by Tob in osteoblasts.	SMAD2 SMAD9	1.64e-04	7	98	2	11163184
Pubmed	Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan.	ERCC6L TUBGCP6 ALDH1A3 SMAD2 SMAD9	1.75e-04	183	98	5	31932471
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	UBOX5 ZNF365 RAB11FIP5 MYO16	1.89e-04	100	98	4	10048485
Pubmed	Thyroid follicle development requires Smad1/5- and endothelial cell-dependent basement membrane assembly.	COL4A3 COL4A6 SMAD9	1.99e-04	40	98	3	27068110
Pubmed	A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.	SMAD2 SMAD9	2.18e-04	8	98	2	19211612
Pubmed	Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells.	SMAD2 SMAD9	2.18e-04	8	98	2	10647776
Pubmed	Computational modelling of Smad-mediated negative feedback and crosstalk in the TGF-β superfamily network.	SMAD2 SMAD9	2.18e-04	8	98	2	23804438
Pubmed	Appearance and persistence of fibronectin in cartilage. Specific interaction of fibronectin with collagen type II.	COL4A3 COL4A6	2.18e-04	8	98	2	3997552
Pubmed	Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium.	COL4A3 COL4A6	2.18e-04	8	98	2	29422532
Pubmed	Mice develop normally without tenascin.	COL4A3 HSPG2	2.18e-04	8	98	2	1383086
Pubmed	Short amino acid sequences derived from C1q receptor (C1q-R) show homology with the alpha chains of fibronectin and vitronectin receptors and collagen type IV.	COL4A3 COL4A6	2.18e-04	8	98	2	1377218
Pubmed	Sex specific retinoic acid signaling is required for the initiation of urogenital sinus bud development.	INHBA ALDH1A3	2.18e-04	8	98	2	25261715
Pubmed	Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.	COL4A3 COL4A6	2.18e-04	8	98	2	10382266
Pubmed	4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis model.	SELP PLG	2.18e-04	8	98	2	38820498
Pubmed	TGF-beta signaling by Smad proteins.	SMAD2 SMAD9	2.18e-04	8	98	2	10708949
Pubmed	Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons.	COL4A3 COL4A6	2.18e-04	8	98	2	10970885
Pubmed	Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.	HSPG2 FASN PLG	2.64e-04	44	98	3	31273033
Pubmed	Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.	ARHGEF28 PRKCE CSMD1	2.64e-04	44	98	3	20200978
Pubmed	Holding their own: the noncanonical roles of Smad proteins.	SMAD2 SMAD9	2.79e-04	9	98	2	19018011
Pubmed	GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways.	SMAD2 SMAD9	2.79e-04	9	98	2	24932701
Pubmed	TGF-beta signal transduction.	SMAD2 SMAD9	2.79e-04	9	98	2	9759503
Pubmed	Combinatorial Smad2/3 Activities Downstream of Nodal Signaling Maintain Embryonic/Extra-Embryonic Cell Identities during Lineage Priming.	SMAD2 SMAD9	2.79e-04	9	98	2	30134160
Pubmed	Altered primordial germ cell migration in the absence of transforming growth factor beta signaling via ALK5.	SMAD2 SMAD9	2.79e-04	9	98	2	15993878
Pubmed	Interactions between BMP-7 and USAG-1 (uterine sensitization-associated gene-1) regulate supernumerary organ formations.	SMAD2 SMAD9	2.79e-04	9	98	2	24816837
Pubmed	Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway.	SMAD2 SMAD9	2.79e-04	9	98	2	14729481
Pubmed	MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation?	COL4A3 COL4A6	2.79e-04	9	98	2	9878537
Pubmed	Prdm16 is required for normal palatogenesis in mice.	SMAD2 SMAD9	2.79e-04	9	98	2	20007998
Pubmed	Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling.	SMAD2 SMAD9	2.79e-04	9	98	2	25155999
Pubmed	Retinal ganglion cell axon sorting at the optic chiasm requires dystroglycan.	COL4A3 HSPG2	2.79e-04	9	98	2	30149005
Pubmed	Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.	SMAD2 SMAD9	2.79e-04	9	98	2	26555259
Pubmed	Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling.	COL4A3 COL4A6	2.79e-04	9	98	2	12101409
Pubmed	The Smad pathway.	SMAD2 SMAD9	2.79e-04	9	98	2	10708948
Pubmed	Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.	SMAD2 SMAD9	2.79e-04	9	98	2	9389648
Pubmed	Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis.	SMAD2 SMAD9	3.48e-04	10	98	2	29986157
Pubmed	Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.	SMAD2 SMAD9	3.48e-04	10	98	2	9436979
Pubmed	Nodal/activin signaling promotes male germ cell fate and suppresses female programming in somatic cells.	INHBA SMAD2	3.48e-04	10	98	2	23221368
Pubmed	TGF-β signaling inhibits canonical BMP signaling pathway during palate development.	SMAD2 SMAD9	3.48e-04	10	98	2	29247325
Pubmed	Extracellular Fibrinogen-binding Protein (Efb) from Staphylococcus aureus Inhibits the Formation of Platelet-Leukocyte Complexes.	SELP PLG	3.48e-04	10	98	2	26627825
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 IGFN1 LINGO3 MDGA2 TYRO3 HMCN2 HMCN1 SIGLEC6 IGSF9 MUSK	6.85e-10	161	71	10	593
GeneFamily	Immunoglobulin like domain containing	SEMA4D HSPG2 MDGA2 TEK TYRO3 HMCN2 SIGIRR PVR IGSF9 MUSK	3.99e-09	193	71	10	594
GeneFamily	Fibronectin type III domain containing	IGFN1 IL31RA TEK TYRO3 SNED1 PTPRJ EBI3 IGSF9 USH2A	1.24e-08	160	71	9	555
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	SELP PAPPA2 CR2 SNED1 CSMD1 SEZ6L	9.16e-08	57	71	6	1179
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	SELP SEMA4D TEK CR2 PTPRJ SIGLEC6 PVR TNFRSF13B	1.52e-04	394	71	8	471
GeneFamily	SMAD family	SMAD2 SMAD9	4.19e-04	8	71	2	750
GeneFamily	Fibulins	HMCN2 HMCN1	4.19e-04	8	71	2	556
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	TEK TYRO3 MUSK	5.17e-04	40	71	3	321
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	SIGIRR IL17RD	1.54e-03	15	71	2	1296
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA4F SEMA4D	2.76e-03	20	71	2	736
Coexpression	NABA_MATRISOME	PAPPA2 COL4A3 COL4A6 SEMA4F SEMA4D HSPG2 INHBA MATN4 MUC5B ARTN SNED1 HMCN2 HMCN1 MEGF6 LGI2 EBI3 OTOGL PLG	2.78e-08	1008	97	18	MM17056
Coexpression	NABA_MATRISOME	PAPPA2 COL4A3 COL4A6 SEMA4F SEMA4D HSPG2 INHBA MATN4 MUC5B ARTN SNED1 HMCN2 HMCN1 MEGF6 LGI2 EBI3 PLG USH2A	3.63e-08	1026	97	18	M5889
Coexpression	NABA_BASEMENT_MEMBRANES	COL4A3 COL4A6 HSPG2 HMCN1 USH2A	3.71e-07	40	97	5	M5887
Coexpression	NABA_CORE_MATRISOME	COL4A3 COL4A6 HSPG2 MATN4 SNED1 HMCN2 HMCN1 LGI2 OTOGL	7.41e-07	270	97	9	MM17057
Coexpression	NABA_CORE_MATRISOME	COL4A3 COL4A6 HSPG2 MATN4 SNED1 HMCN2 HMCN1 LGI2 USH2A	8.63e-07	275	97	9	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	MATN4 SNED1 HMCN2 HMCN1 LGI2 OTOGL	7.89e-05	191	97	6	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	MATN4 SNED1 HMCN2 HMCN1 LGI2 USH2A	9.10e-05	196	97	6	M3008
Coexpression	GSE22886_NEUTROPHIL_VS_MONOCYTE_UP	COL4A3 ERCC6L LGI2 PTPRJ ELAPOR1 RAB11FIP5	9.36e-05	197	97	6	M4466
Coexpression	GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	SEMA4D ACD TYRO3 YWHAH-AS1 RAB3IL1 MUSK	9.89e-05	199	97	6	M8164
Coexpression	OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP	INHBA FASN EBI3	1.07e-04	25	97	3	M40987
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 ABCA13 MDGA2 MUC5B HMCN1 OTOGL CSMD1 USH2A MYO16	2.76e-10	184	97	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 ABCA13 MDGA2 MUC5B HMCN1 OTOGL CSMD1 USH2A MYO16	2.76e-10	184	97	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 ABCA13 MDGA2 MUC5B HMCN1 OTOGL CSMD1 USH2A MYO16	2.76e-10	184	97	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGFN1 ARTN KLHL31 ZNF469 HMCN2 ELAPOR1 IGSF9 PLG ALDH1A3	5.05e-10	197	97	9	4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_3\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	IGFN1 ARTN KLHL31 ZNF469 HMCN2 ELAPOR1 IGSF9 PLG ALDH1A3	5.05e-10	197	97	9	2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGFN1 ARTN KLHL31 ZNF469 HMCN2 ELAPOR1 IGSF9 PLG ALDH1A3	5.05e-10	197	97	9	0f37afad46b94c748a149d9ee681472d7a3e6937
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	SELP LINGO3 TEK SNED1 HMCN1 ALDH1A3 MUSK	8.30e-08	167	97	7	d2230c894ccf9dbba9196e079ae81f384d43da63
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SELP HSPG2 INHBA TEK HMCN1 CSMD1 SMAD9	1.93e-07	189	97	7	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PAPPA2 COL4A3 ARHGEF28 ABCA13 PTPRJ PLEKHH2 PLEKHA7	2.30e-07	194	97	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	remission-multiplets\|remission / disease stage, cell group and cell class	SELP INHBA ABCA13 TMPRSS5 ZNF469 MAB21L3	9.19e-07	149	97	6	e9974260a5f2999b363f306cae005698c912893a
ToppCell	Basal_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	LHFPL4 MDGA2 LINC00311 HMCN2 HMCN1 ALDH1A3	1.29e-06	158	97	6	51e3ed1b91b010404d66e3e7efdbffc0c815e25b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D ABCA13 LGI2 IGSF9 PLEKHH2 SMAD9	2.42e-06	176	97	6	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	21-Trachea-Epithelial-Submucosal_gland\|Trachea / Age, Tissue, Lineage and Cell class	INHBA TMPRSS5 MUC5B ELAPOR1 ALDH1A3 IL17RD	2.58e-06	178	97	6	3e406e38eea0d38dc25edecf703c4c89ec6a28e0
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SELP HSPG2 TEK ZNF365 HMCN2 HMCN1	2.67e-06	179	97	6	8c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 SEMA4D ABCA13 LGI2 ALDH1A3 SMAD9	3.03e-06	183	97	6	738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 SEMA4D ABCA13 LGI2 ALDH1A3 SMAD9	3.03e-06	183	97	6	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 SEMA4D ABCA13 LGI2 ALDH1A3 SMAD9	3.13e-06	184	97	6	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SELP HSPG2 TEK HMCN2 CSMD1 SMAD9	3.13e-06	184	97	6	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA13 MAB21L3 PTPRJ PVR ELAPOR1 CSMD1	3.23e-06	185	97	6	686ed7550c6acd18e71e0076936ec5b07389adbd
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP COL4A3 HSPG2 ARHGEF28 TEK MEGF6	3.33e-06	186	97	6	1e67bfb248366d7395efdd2d5e70a97bdb2e68af
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	SELP HSPG2 INHBA TEK HMCN1 SMAD9	3.43e-06	187	97	6	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DBX2 MATN4 MAB21L3 GRIN3A CSMD1 SEZ6L	3.54e-06	188	97	6	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DBX2 MATN4 MAB21L3 GRIN3A CSMD1 SEZ6L	3.54e-06	188	97	6	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 SEMA4D ABCA13 LGI2 ALDH1A3 PLEKHH2	3.65e-06	189	97	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SELP COL4A3 HSPG2 ARHGEF28 TEK MEGF6	3.76e-06	190	97	6	3b9abc25b17e7295356ded57ff2ca519fa9f2686
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	SELP HSPG2 INHBA TEK HMCN1 SMAD9	4.00e-06	192	97	6	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	HSPG2 INHBA TEK SNED1 HMCN1 SMAD9	4.12e-06	193	97	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 LGI2 IGSF9 ALDH1A3 PLEKHH2 IL17RD	4.12e-06	193	97	6	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	SELP HSPG2 INHBA TEK SNED1 HMCN1	4.12e-06	193	97	6	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SELP HSPG2 TEK SNED1 STARD9 SMAD9	4.24e-06	194	97	6	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	SELP HSPG2 INHBA TEK HMCN1 SMAD9	4.24e-06	194	97	6	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SELP HSPG2 TEK SNED1 STARD9 SMAD9	4.24e-06	194	97	6	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SELP HSPG2 TEK SNED1 STARD9 SMAD9	4.24e-06	194	97	6	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARHGEF28 ABCA13 HMCN2 HMCN1 OTOGL CSMD1	4.37e-06	195	97	6	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARHGEF28 ABCA13 HMCN2 HMCN1 OTOGL CSMD1	4.37e-06	195	97	6	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CR2 HMCN1 LGI2 ALDH1A3 MYO16 SMAD9	4.37e-06	195	97	6	1be9502577267ca2a04656a99d57e3e2f124d92e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SELP HSPG2 TEK SNED1 STARD9 SMAD9	4.50e-06	196	97	6	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	distal-1-Hematologic-B_cell\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LINGO3 CR2 RGS7 GUCY2C TNFRSF13B IL17RD	4.50e-06	196	97	6	f442060d743b3ad2f9e5e343d4696411eef7f498
ToppCell	distal-Hematologic-B_cell-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LINGO3 CR2 RGS7 GUCY2C TNFRSF13B IL17RD	4.50e-06	196	97	6	be520c09d7e41d08d5f5154bfed3d67c7c1067d4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SELP HSPG2 TEK SNED1 STARD9 SMAD9	4.63e-06	197	97	6	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SELP HSPG2 TEK SNED1 STARD9 SMAD9	4.77e-06	198	97	6	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MDGA2 TEK RGS7 ALDH1A3 CSMD1 SEZ6L	4.91e-06	199	97	6	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TEK RGS7 ALDH1A3 CSMD1 PLEKHH2 SEZ6L	4.91e-06	199	97	6	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MDGA2 TEK RGS7 ALDH1A3 CSMD1 SEZ6L	4.91e-06	199	97	6	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MDGA2 TEK CSMD1 PLEKHH2 MYO16 SEZ6L	5.05e-06	200	97	6	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MDGA2 TEK CSMD1 PLEKHH2 MYO16 SEZ6L	5.05e-06	200	97	6	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MDGA2 TEK CSMD1 PLEKHH2 MYO16 SEZ6L	5.05e-06	200	97	6	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LINGO3 MDGA2 TEK ALDH1A3 CSMD1 SEZ6L	5.05e-06	200	97	6	ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MDGA2 TEK CSMD1 PLEKHH2 MYO16 SEZ6L	5.05e-06	200	97	6	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MDGA2 TEK CSMD1 PLEKHH2 MYO16 SEZ6L	5.05e-06	200	97	6	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	MDGA2 TEK CSMD1 PLEKHH2 MYO16 SEZ6L	5.05e-06	200	97	6	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Striatum / BrainAtlas - Mouse McCarroll V32	RHBDF2 TEK HMCN1 SIGIRR ALDH1A3	1.25e-05	137	97	5	306b11b3b9e5fd562d845fb5eaa4ac982864efce
ToppCell	Striatum-Endothelial-ENDOTHELIAL_STALK\|Striatum / BrainAtlas - Mouse McCarroll V32	RHBDF2 TEK HMCN1 SIGIRR ALDH1A3	1.25e-05	137	97	5	d37f425b13bc046baa1f8619b98a16b936f88ff6
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SELP RHBDF2 TEK HMCN1 SIGIRR	1.34e-05	139	97	5	34398a6f21a1e670497655a7bb7f3cde9e117560
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SELP RHBDF2 TEK HMCN1 SIGIRR	1.34e-05	139	97	5	450c4152c9fe4ec503271bb3cf93739918c59509
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 HSPG2 ABCA13 LGI2 ALDH1A3	1.65e-05	145	97	5	8da10bc6611976e1ec85e09f04a2dc5bf6555c9e
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	UBOX5 ZNF365 SIGLEC6 PLEKHH2 IL17RD	1.70e-05	146	97	5	cffa91d76606f74553d81150adbb23b003746316
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	ABCA13 MDGA2 CSMD1 USH2A SEZ6L	1.70e-05	146	97	5	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TMPRSS5 OTOGL TNFRSF13B IGSF9	1.77e-05	71	97	4	499262154a694d9f84358de9f5deff0d022c7632
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TMPRSS5 OTOGL TNFRSF13B IGSF9	1.77e-05	71	97	4	00ca08c442de977f909f1691c6fa40e7382d02dd
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	MDGA2 RGS7 CSMD1 USH2A MYO16	2.57e-05	159	97	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	MDGA2 ZNF831 RGS7 USH2A MYO16	2.89e-05	163	97	5	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	IL31RA INHBA ZNF469 HMCN2 LGI2	2.98e-05	164	97	5	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INHBA MATN4 TYRO3 PVR MYO16	3.06e-05	165	97	5	622aca1d49bd8c917b131e4f4959d9dba411d22b
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A3 ARHGEF28 FRMPD1 ZNF365 MYO16	3.15e-05	166	97	5	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A3 ARHGEF28 FRMPD1 ZNF365 MYO16	3.15e-05	166	97	5	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	CV-Mild-3\|Mild / Virus stimulation, Condition and Cluster	ZNF132 ERCC6L DBF4B AHDC1 RAB11FIP5	3.15e-05	166	97	5	5599f90fc0e15a3670b03187085eba91228390a2
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A3 ARHGEF28 FRMPD1 ZNF365 MYO16	3.25e-05	167	97	5	bebc2493a2ee41920b21c2b774a1c5a9619315c4
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A3 ARHGEF28 FRMPD1 ZNF365 MYO16	3.25e-05	167	97	5	9f2661729a2d58e17a9203a563d538c08a3dbbbc
ToppCell	droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A6 SEMA4D INHBA MUC5B RAB3IL1	3.25e-05	167	97	5	589c0acfeb4d70931b6726fb3331d85a54e74d56
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INHBA MATN4 TYRO3 PVR MYO16	3.25e-05	167	97	5	3c06894fc6177f3c204094719904da42f08b9af8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-CR\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IL31RA MAB21L3 IGSF9 MESP2	3.27e-05	83	97	4	1ab68323518adc7fd0a459b41fad12d60f97eb5c
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IL31RA MAB21L3 IGSF9 MESP2	3.27e-05	83	97	4	75b27d91a4473286f4b40027e96ac5246f5abe5b
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 CR2 GUCY2C SIGLEC6 TNFRSF13B	3.44e-05	169	97	5	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	E16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA13 MUC5B CBS MAB21L3 ELAPOR1	3.44e-05	169	97	5	08ac28c5ad8f5c5f9f54af341bf39e8f9417636e
ToppCell	3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages\|Lung / Manually curated celltypes from each tissue	MEGF6 LGI2 EBI3 YWHAH-AS1 RAB3IL1	3.44e-05	169	97	5	241644823e6f949aaf4c671d4579721d7ef6b0e5
ToppCell	E16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA13 MUC5B CBS MAB21L3 ELAPOR1	3.44e-05	169	97	5	e5abd41db1e6724ad900e37658fa063b8e522908
ToppCell	10x5'-Lung-Lymphocytic_B-Memory_B_cells\|Lung / Manually curated celltypes from each tissue	COL4A3 CR2 RGS7 GUCY2C TNFRSF13B	3.74e-05	172	97	5	2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCN11A DNAJC6 RGS7 NYAP1 SEZ6L	4.17e-05	176	97	5	04dad262929581872e5bbc66cd8182c963e7e52f
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP EBI3 TNFRSF13B RAB11FIP5 RAB3IL1	4.17e-05	176	97	5	e29a13b8152ee84ca82fd1158d96d3f112e3cde3
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP EBI3 TNFRSF13B RAB11FIP5 RAB3IL1	4.17e-05	176	97	5	00510bf8ede0945dfcbd58cc8f34fddf914b6e49
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SELP HSPG2 TEK HMCN2 HMCN1	4.17e-05	176	97	5	52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a
ToppCell	droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4F TMPRSS5 MATN4 DNAJC6 CSMD1	4.40e-05	178	97	5	3e8aacb27ed1a3c3978e21dddddd0828f8000692
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	INHBA ZNF365 TYRO3 SNED1 ZNF469	4.52e-05	179	97	5	9ba8693fba2175bca9ff9735cc04e657abeb9084
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGEF28 DNAJC6 RGS7 CSMD1 SEZ6L	4.52e-05	179	97	5	228d12ed1c8dc92aefbcea4aaf7d108783c22be0
ToppCell	Ciliated_cells-A-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	ABCA13 PIH1D2 MUC5B ALDH1A3 PLEKHH2	4.52e-05	179	97	5	1c41314b6fcfcac8d62034e7037570120d58f20f
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	SELP TEK PTPRJ PRKCE ASB1	4.52e-05	179	97	5	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4F TMPRSS5 MATN4 CSMD1 NYAP1	4.64e-05	180	97	5	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A3 COL4A6 HSPG2 TYRO3 RAB3IL1	4.64e-05	180	97	5	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4F TMPRSS5 MATN4 CSMD1 NYAP1	4.64e-05	180	97	5	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4F TMPRSS5 MATN4 CSMD1 NYAP1	4.64e-05	180	97	5	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D ABCA13 LGI2 PLEKHH2 SMAD9	4.76e-05	181	97	5	6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	CR2 EBI3 GUCY2C SIGLEC6 TNFRSF13B	4.76e-05	181	97	5	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 COL4A6 SEMA4D ABCA13 LGI2	4.76e-05	181	97	5	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 SEMA4D ABCA13 LGI2 SMAD9	4.76e-05	181	97	5	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4D ABCA13 LGI2 IGSF9 PLEKHH2	4.89e-05	182	97	5	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	COL4A3 CR2 RGS7 GUCY2C TNFRSF13B	4.89e-05	182	97	5	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	COL4A6 HMCN1 ELAPOR1 ALDH1A3 NYAP1	5.02e-05	183	97	5	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	Severe_COVID-19-B_cell-B_cell\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	COL4A3 CR2 EBI3 SIGLEC6 TNFRSF13B	5.02e-05	183	97	5	5634e528001c389efd1e380f01ad40072f60e943
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	CR2 EBI3 GUCY2C SIGLEC6 TNFRSF13B	5.02e-05	183	97	5	9b64d2d143525e6f48a191facfd101462ff36324
Drug	Griseofulvin [126-07-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SELP PAPPA2 ARHGEF28 INHBA FRMPD1 GRIK5 SIGLEC6 PVR PRKCE	1.67e-07	199	96	9	4687_UP
Drug	Equilin [474-86-2]; Up 200; 15uM; HL60; HT_HG-U133A	KDM5B GRIK5 NEK9 SNED1 PTPRJ RAB3IL1 MUSK SEZ6L	1.88e-06	197	96	8	3039_UP
Drug	Dietary Sucrose	SELP LHFPL4 DBX2 LINGO3 TMPRSS5 MATN4 NEK9 RGS7 USP31 FASN PRKCE ASB1 MESP2 GRIN3A IL17RD	9.09e-06	942	96	15	ctd:D019422
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; PC3; HT_HG-U133A	KDM5B INHBA FRMPD1 MUC5B GRIK5 ARTN CBS	1.50e-05	188	96	7	5733_UP
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	COL4A6 SCN11A YWHAH-AS1 PVR ASB1 RAB3IL1 SEZ6L	1.78e-05	193	96	7	4676_UP
Drug	Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	FRMPD1 MUC5B ARTN ELAPOR1 PRKCE RAB3IL1 SEZ6L	1.96e-05	196	96	7	3314_UP
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; MCF7; HT_HG-U133A	PAPPA2 SCN11A DBF4B ARTN UBOX5 NEK9 PRKCE	1.96e-05	196	96	7	4714_UP
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SEMA4D HSPG2 INHBA NEK9 ZNF365 PVR RAB11FIP5	2.03e-05	197	96	7	3212_DN
Drug	Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	PAPPA2 HSPG2 MEGF6 PVR PRKCE ASB1 RAB3IL1	2.03e-05	197	96	7	6829_UP
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SCN11A INHBA FRMPD1 ARTN UBOX5 MEGF6 SIGLEC6	2.10e-05	198	96	7	3865_UP
Drug	Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A	SEMA4F INHBA AMBRA1 GRIK5 ZNF365 AHDC1 PVR	2.10e-05	198	96	7	6502_DN
Drug	Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A	COL4A3 SEMA4D HSPG2 UBOX5 AHDC1 SNED1 ASB1	2.17e-05	199	96	7	2655_UP
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A	SCN11A INHBA RGS7 SIGLEC6 PVR TNFRSF13B	1.55e-04	190	96	6	5786_UP
Drug	3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A	COL4A3 ARHGEF28 ARTN UBOX5 NEK9 MEGF6	1.64e-04	192	96	6	5624_UP
Drug	alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	COL4A6 ARTN NEK9 SNED1 SIGLEC6 PRKCE	1.74e-04	194	96	6	4531_UP
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A	PAPPA2 COL4A6 SEMA4F NEK9 SIGLEC6 TNFRSF13B	1.74e-04	194	96	6	3785_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A	SEMA4F SEMA4D ARHGEF28 ARTN PRKCE PLG	1.74e-04	194	96	6	2893_UP
Drug	Dubinidine [22964-77-8]; Up 200; 14.6uM; PC3; HT_HG-U133A	SCN11A GRIK5 ARTN NEK9 PVR TNFRSF13B	1.74e-04	194	96	6	5774_UP
Drug	cyclobutadiene	CR2 TYRO3	1.74e-04	5	96	2	CID000136879
Drug	Oxethazaine [126-27-2]; Up 200; 8.6uM; HL60; HG-U133A	AMBRA1 LETM1 MEGF6 YWHAH-AS1 TNFRSF13B RAB3IL1	1.79e-04	195	96	6	1984_UP
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CEP104 SEMA4F SEMA4D DBF4B NEK9 SIGLEC6	1.79e-04	195	96	6	6821_DN
Drug	Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A	INHBA AMBRA1 GRIK5 UBOX5 PVR ASB1	1.79e-04	195	96	6	6510_DN
Drug	Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A	SEMA4F GRIK5 ARTN MEGF6 PVR ELAPOR1	1.84e-04	196	96	6	3372_UP
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	ERCC6L GRIK5 NEK9 PVR TNFRSF13B PRKCE	1.84e-04	196	96	6	2198_DN
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; HL60; HT_HG-U133A	ZNF132 RHBDF2 INHBA FRMPD1 UBOX5 NEK9	1.84e-04	196	96	6	2534_DN
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	PAPPA2 SEMA4D SCN11A ARTN PVR SEZ6L	1.84e-04	196	96	6	5793_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A	DBF4B MUC5B ARTN ZNF365 PVR RAB3IL1	1.84e-04	196	96	6	3277_UP
Drug	haloperidol; Up 200; 10uM; PC3; HT_HG-U133A	COL4A3 COL4A6 SCN11A ARTN EBI3 PRKCE	1.84e-04	196	96	6	4468_UP
Drug	Pentetic acid [67-43-6]; Up 200; 10.2uM; PC3; HT_HG-U133A	COL4A6 SCN11A ARTN NEK9 PVR PRKCE	1.84e-04	196	96	6	4669_UP
Drug	Sulmazole [73384-60-8]; Up 200; 14uM; MCF7; HT_HG-U133A	PAPPA2 HSPG2 ARHGEF28 SNED1 TNFRSF13B RAB3IL1	1.84e-04	196	96	6	4127_UP
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	PAPPA2 COL4A6 SCN11A ARTN SIGLEC6 RAB3IL1	1.84e-04	196	96	6	3816_DN
Drug	Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HT_HG-U133A	SELP GRIK5 ARTN SIGLEC6 PVR PRKCE	1.89e-04	197	96	6	4012_UP
Drug	alpha-Santonin [481-06-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	CEP104 COL4A6 SCN11A INHBA GRIK5 SIGLEC6	1.89e-04	197	96	6	3877_UP
Drug	Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	HSPG2 SCN11A MUC5B GRIK5 TEK YWHAH-AS1	1.89e-04	197	96	6	6099_UP
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	GRIK5 UBOX5 AHDC1 PVR ASB1 RAB3IL1	1.89e-04	197	96	6	5400_DN
Drug	Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	COL4A3 GRIK5 ARTN UBOX5 NEK9 TNFRSF13B	1.89e-04	197	96	6	5638_UP
Drug	0393-0188; Up 200; 10uM; PC3; HT_HG-U133A	HSPG2 INHBA AMBRA1 GRIK5 PVR RAB3IL1	1.89e-04	197	96	6	7510_UP
Drug	Meglumine [6284-40-8]; Down 200; 20.4uM; HL60; HT_HG-U133A	CEP104 INHBA UBOX5 PVR ASB1 RAB3IL1	1.89e-04	197	96	6	3068_DN
Drug	Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; MCF7; HT_HG-U133A	SELP PAPPA2 SCN11A DBF4B FRMPD1 NEK9	1.89e-04	197	96	6	2229_UP
Drug	Etodolac [41340-25-4]; Down 200; 14uM; MCF7; HT_HG-U133A	SEMA4D HSPG2 GRIK5 ARTN NEK9 PVR	1.89e-04	197	96	6	2254_DN
Drug	SC-58125; Down 200; 10uM; MCF7; HG-U133A	PAPPA2 ERCC6L GRIK5 LETM1 PISD SEZ6L	1.89e-04	197	96	6	208_DN
Drug	Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; PC3; HT_HG-U133A	PAPPA2 COL4A3 ARTN CBS MEGF6 SIGLEC6	1.89e-04	197	96	6	4014_UP
Drug	Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A	PAPPA2 ARHGEF28 INHBA GRIK5 SNED1 MEGF6	1.89e-04	197	96	6	5435_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; HL60; HT_HG-U133A	PAPPA2 COL4A3 GRIK5 NEK9 LETM1 PVR	1.94e-04	198	96	6	2188_DN
Drug	Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	COL4A3 SEMA4F RGS7 SNED1 PVR SEZ6L	1.94e-04	198	96	6	4351_UP
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A	COL4A6 INHBA FRMPD1 GRIK5 SNED1 PLG	1.94e-04	198	96	6	4695_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	PAPPA2 SEMA4F DBF4B GRIK5 ARTN PVR	1.94e-04	198	96	6	6031_DN
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A	DBF4B ARTN AHDC1 PVR RAB11FIP5 ASB1	1.94e-04	198	96	6	5451_DN
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	CEP104 COL4A3 FRMPD1 ARTN MEGF6 RAB3IL1	1.94e-04	198	96	6	4703_UP
Drug	Enoxacin [74011-58-8]; Up 200; 12.4uM; PC3; HT_HG-U133A	PAPPA2 COL4A6 SCN11A ARTN PVR PRKCE	1.94e-04	198	96	6	4655_UP
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; HL60; HG-U133A	SELP SEMA4F ARTN UBOX5 SIGLEC6 SEZ6L	1.94e-04	198	96	6	1391_UP
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	SEMA4D SCN11A GRIK5 ARTN SIGLEC6 SEZ6L	1.94e-04	198	96	6	4525_UP
Drug	Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	PAPPA2 SEMA4F UBOX5 NEK9 ZNF365 PVR	1.94e-04	198	96	6	3313_DN
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	SEMA4D DBF4B GRIK5 ARTN AHDC1 PVR	1.94e-04	198	96	6	5445_DN
Drug	Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	GRIK5 NEK9 SNED1 PVR PRKCE RAB3IL1	1.94e-04	198	96	6	4594_UP
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A	SCN11A FRMPD1 GRIK5 NEK9 PRKCE SEZ6L	2.00e-04	199	96	6	4494_UP
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SEMA4D KDM5B AHDC1 MEGF6 PRKCE ASB1	2.00e-04	199	96	6	7029_UP
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	PAPPA2 COL4A3 SEMA4F SCN11A INHBA ELAPOR1	2.00e-04	199	96	6	4810_UP
Drug	Tropine [120-29-6]; Up 200; 28.4uM; PC3; HT_HG-U133A	SEMA4D ARTN NEK9 SIGLEC6 PVR SEZ6L	2.00e-04	199	96	6	5790_UP
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	PAPPA2 DBF4B DNAJC6 PVR ASB1 SEZ6L	2.00e-04	199	96	6	4946_UP
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A	COL4A3 ARTN NEK9 SNED1 PVR TNFRSF13B	2.00e-04	199	96	6	6521_UP
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	PAPPA2 SEMA4D INHBA ARTN PVR ASB1	2.05e-04	200	96	6	1704_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A	COL4A6 SEMA4D ARTN CBS RAB3IL1 SEZ6L	2.05e-04	200	96	6	3822_DN
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A	SEMA4F ZNF132 FRMPD1 MUSK SEZ6L SMAD9	2.05e-04	200	96	6	6030_UP
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	COL4A3 FRMPD1 DNAJC6 UBOX5 LETM1 PRKCE	2.05e-04	200	96	6	3127_UP
Drug	dl-cystine	COL4A3 GRIK5 CBS RGS7 GUCY2C	2.11e-04	128	96	5	CID000000595
Drug	Orphenadrine	COL4A3 RHBDF2 MATN4 GRIK5 STARD9 PVR RAB11FIP5 CSMD1	2.38e-04	388	96	8	ctd:D009966
Disease	alpha-linolenic acid measurement	CSMD1 RAB3IL1 MUSK	7.06e-05	25	95	3	EFO_0007759
Disease	chronic kidney disease, APOL1 risk genotype carrier status	OTOGL PLG	1.02e-04	5	95	2	EFO_0003884, EFO_0009324
Disease	IMMUNODEFICIENCY, COMMON VARIABLE, 2	CR2 TNFRSF13B	1.02e-04	5	95	2	240500
Disease	Immunodeficiency, common variable, 2	CR2 TNFRSF13B	1.02e-04	5	95	2	cv:C3150354
Disease	coronary artery disease	ZNF831 TEK NEK9 AHDC1 PTPRJ PRKCE PLG PLEKHH2 PLEKHA7 SMAD2 ATG16L2 SEZ6L SMAD9	1.17e-04	1194	95	13	EFO_0001645
Disease	cholesteryl ester 22:6 measurement	CSMD1 RAB3IL1 MUSK	1.50e-04	32	95	3	EFO_0010350
Disease	coronary aneurysm	MESP2 GRIN3A CSMD1	1.96e-04	35	95	3	EFO_1000881
Disease	level of Phosphatidylcholine (18:2_20:3) in blood serum	RAB3IL1 MUSK	2.13e-04	7	95	2	OBA_2045108
Disease	phosphatidylcholine 35:5 measurement	RAB3IL1 MUSK	2.13e-04	7	95	2	EFO_0021472
Disease	multiple system atrophy	MDGA2 USP31 ASB1	2.93e-04	40	95	3	EFO_1001050
Disease	response to lamotrigine	GRIN3A CSMD1	3.64e-04	9	95	2	EFO_0007661
Disease	phosphatidylcholine 39:5 measurement	RAB3IL1 MUSK	3.64e-04	9	95	2	EFO_0021476
Disease	level of Phosphatidylcholine (O-18:1_18:2) in blood serum	RAB3IL1 MUSK	3.64e-04	9	95	2	OBA_2045129
Disease	level of Phosphatidylcholine (18:0_20:5) in blood serum	RAB3IL1 MUSK	3.64e-04	9	95	2	OBA_2045095
Disease	cholesteryl ester 22:4 measurement	RAB3IL1 MUSK	4.54e-04	10	95	2	EFO_0021443
Disease	Immunoglobulin Deficiency, Late-Onset	CR2 TNFRSF13B	5.54e-04	11	95	2	C2936665
Disease	Acquired Hypogammaglobulinemia	CR2 TNFRSF13B	5.54e-04	11	95	2	C2936664
Disease	level of Sterol ester (27:1/20:5) in blood serum	RAB3IL1 MUSK	5.54e-04	11	95	2	OBA_2045197
Disease	lysophosphatidylcholine 20:2 measurement	RAB3IL1 MUSK	5.54e-04	11	95	2	EFO_0021458
Disease	sialic acid-binding Ig-like lectin 14 measurement	ARHGEF28 SIGLEC6	6.63e-04	12	95	2	EFO_0008284
Disease	collagen disease (implicated_via_orthology)	COL4A3 COL4A6	6.63e-04	12	95	2	DOID:854 (implicated_via_orthology)
Disease	eye colour measurement	INHBA TMPRSS5 MDGA2 ZNF469 USH2A	7.10e-04	218	95	5	EFO_0009764
Disease	facial morphology	DNAJC6 LGI2 CSMD1	7.51e-04	55	95	3	EFO_0004743
Disease	triacylglycerol 52:2 measurement	LGI2 CSMD1 MUSK	7.51e-04	55	95	3	EFO_0010414
Disease	Common variable immunodeficiency	CR2 TNFRSF13B	7.82e-04	13	95	2	cv:C0009447
Disease	level of Phosphatidylcholine (O-16:0_20:4) in blood serum	RAB3IL1 MUSK	7.82e-04	13	95	2	OBA_2045116
Disease	Bipolar Disorder	ABCA13 GRIK5 CBS STARD9 GRIN3A CSMD1 SEZ6L	8.98e-04	477	95	7	C0005586
Disease	glycodeoxycholate measurement	GRIK5 CSMD1	9.10e-04	14	95	2	EFO_0010493
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	RAB3IL1 MUSK	9.10e-04	14	95	2	OBA_2045142
Disease	diacylglycerol 38:4 measurement	RAB3IL1 MUSK	9.10e-04	14	95	2	EFO_0020066
Disease	delta-6 desaturase measurement	LHFPL4 MUSK	1.05e-03	15	95	2	EFO_0007765
Disease	oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement	RAB3IL1 MUSK	1.05e-03	15	95	2	EFO_0800508
Disease	Common Variable Immunodeficiency	CR2 TNFRSF13B	1.05e-03	15	95	2	C0009447
Disease	level of Phosphatidylcholine (18:0_18:2) in blood serum	RAB3IL1 MUSK	1.20e-03	16	95	2	OBA_2045090
Disease	eicosapentaenoate EPA; 20:5n3 measurement	GRIK5 MUSK	1.35e-03	17	95	2	EFO_0021049
Disease	unipolar depression, bipolar disorder	TMPRSS5 GRIK5 TUBGCP6 STARD9	1.65e-03	156	95	4	EFO_0003761, MONDO_0004985
Disease	Osteochondrodysplasias	HSPG2 PISD	1.69e-03	19	95	2	C0029422
Disease	lysophosphatidylcholine 20:5 measurement	RAB3IL1 MUSK	1.69e-03	19	95	2	EFO_0010364
Disease	diacylglycerol 38:5 measurement	RAB3IL1 MUSK	1.69e-03	19	95	2	EFO_0020067
Disease	diacylglycerol 38:3 measurement	RAB3IL1 MUSK	1.69e-03	19	95	2	EFO_0020065
Disease	pentachlorophenol measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022071
Disease	parathion measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022070
Disease	potassium chromate measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022072
Disease	mercuric chloride measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022068
Disease	heptachlor epoxide measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022067
Disease	methoxychlor measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022052
Disease	azinphos methyl measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022055
Disease	aldrin measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022054
Disease	dicofol measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022060
Disease	disulfoton measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022062
Disease	dieldrin measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022061
Disease	endrin measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022064
Disease	endosulfan measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022063
Disease	heptachlor measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022066
Disease	ethion measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022065
Disease	chlorpyrifos measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022057
Disease	cadmium chloride measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022056
Disease	diazinon measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022059
Disease	dibutyl phthalate measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0022058
Disease	environmental exposure measurement	SELP RGS7 USH2A	1.71e-03	73	95	3	EFO_0008360
Disease	juvenile idiopathic arthritis	ABCA13 FASN MESP2	1.78e-03	74	95	3	EFO_0002609
Disease	DDT metabolite measurement	SELP RGS7 USH2A	1.78e-03	74	95	3	EFO_0007886
Disease	myocardial infarction (biomarker_via_orthology)	SELP INHBA TEK SMAD2	1.81e-03	160	95	4	DOID:5844 (biomarker_via_orthology)
Disease	maximal midexpiratory flow rate	TUBGCP6 MYO16	1.88e-03	20	95	2	EFO_0004313
Disease	coagulation factor V measurement	SELP MUSK	1.88e-03	20	95	2	EFO_0008087
Disease	alpha-tocopherol measurement	PRKCE USH2A	1.88e-03	20	95	2	EFO_0007898
Disease	phosphatidylserines measurement	GRIK5 MUSK	2.48e-03	23	95	2	EFO_0020049
Disease	level of Phosphatidylethanolamine (16:0_18:2) in blood serum	RAB3IL1 MUSK	2.70e-03	24	95	2	OBA_2045136
Disease	age at menarche	PAPPA2 SEMA4D INHBA DNAJC6 CSMD1 PLEKHA7 SMAD2	3.11e-03	594	95	7	EFO_0004703
Disease	blood rubidium measurement	ABCA13 TEK	3.17e-03	26	95	2	EFO_0021529
Disease	lysophosphatidylethanolamine 18:2 measurement	RAB3IL1 MUSK	3.17e-03	26	95	2	EFO_0010369

Protein segments in the cluster

Peptide	Gene	Start	Entry
WQRLKTPHGAPVACS	LINC00311	56	Q8N616
HSQDITIPQCPLGWR	COL4A6	1581	Q14031
RFWDSRGPHCTQVIP	ATG16L2	486	Q8NAA4
WSGQTPVCVPITCGH	CSMD1	2726	Q96PZ7
HSQTTDIPPCPHGWI	COL4A3	1561	Q01955
WLPCTPLRIAATAGH	ASB1	76	Q9Y576
TRHEPIGVCGAITPW	ALDH1A3	166	P47895
AAPSHRVVQAWTCLP	CFAP46	2586	Q8IYW2
EPTSGVDPCSRHSLW	ABCA13	4001	Q86UQ4
RCWTPSEPESVHQAP	AHDC1	636	Q5TGY3
RTPWCVTFHPTISGL	AMBRA1	96	Q9C0C7
LASCWIIVRSSPTPG	INHBA	11	P08476
SPLNPAHNGRVCSTW	MUC5B	66	Q9HC84
VPWKSTDPCQGHRES	RAB3IL1	21	Q8TBN0
LRCSATGSPAPTIHW	HSPG2	3231	P98160
AGPSRWLPTHVQVTV	RAB11FIP5	11	Q9BXF6
PIWIRIGVHSGPCAA	GUCY2C	916	P25092
GCTLWPQSSKHTLPT	ARHGEF28	406	Q8N1W1
HAGVGTCPSPQSWIS	YWHAH-AS1	66	Q9Y442
VHQPWCNITGLRPAT	PTPRJ	166	Q12913
LPNLSTPRGWHCAVT	KLHL31	496	Q9H511
HSPWAGPIRAVAITV	IL17RD	291	Q8NFM7
PWETQLQLTGPRCHT	MATN4	16	O95460
QCSLPASWRPVTLTH	DOLPP1	6	Q86YN1
CTSWPRPIFGSLHHV	NEK9	696	Q8TD19
LSWEPACPVSGHVSL	IL17REL	221	Q6ZVW7
HLCWPTVPNPAESSI	IL31RA	551	Q8NI17
CLVGPSIWSPSLHSV	MYO16	1266	Q9Y6X6
TCHSTGIPAPTVSWS	HMCN2	3871	Q8NDA2
TAWSLRHAVGPRPQT	PRKCE	21	Q02156
GGLSTLSHCPWPRQQ	ARTN	6	Q5T4W7
PQTPGRCWSHSAEVV	MESP2	336	Q0VG99
SRWRVAVPHTPGLCT	ELAPOR1	66	Q6UXG2
VAVGPQCLPVRGWHS	LETM1	96	O95202
WVTPQHRPVTATSAG	LINGO3	441	P0C6S8
VSDVAPTRPRWNTHG	TUBGCP6	1121	Q96RT7
VPSISQGLRIWLCPH	KDM5B	1206	Q9UGL1
VWLISHEPGTPLCGT	AP5M1	6	Q9H0R1
VSGWGVLPCPVAHSQ	LHFPL4	231	Q7Z7J7
GEPSSQIWRHPTLCH	PLEKHH2	941	Q8IVE3
TCLVTGHPRPQIRWT	MDGA2	61	Q7Z553
WCPGNRPVITSHHLQ	MAB21L3	271	Q8N8X9
ITCTASGVPFPSIHW	HMCN1	3916	Q96RW7
GAVHLQPWTTAPRAA	GRIN3A	51	Q8TCU5
SIVCTGRRQWHPDPV	PAPPA2	1711	Q9BXP8
IHAPTVSGWRSPRFC	CEP104	26	O60308
HTDNTWVPGVPTCIK	CR2	831	P20023
LLLCTHEGTWSQPAP	CR2	891	P20023
CPSIWDVPQQHSSPR	DBX2	276	Q6ZNG2
VTWGCLIPHDTTPLH	DBF4B	516	Q8NFT6
VVLPWRPARAHSCTT	FRMPD1	1376	Q5SYB0
AARGHSWPCLQQTPT	EBI3	71	Q14213
SECSWPIRQAPSLHN	DNAJC6	126	O75061
RCTWQLGRPASESPH	CBS	51	P35520
NGHWSTTVPTCQAGP	SELP	751	P16109
QGICPVGRSWHSLTP	KLHDC2	261	Q9Y2U9
VPACSHVPTWSARLI	CRIPAK	176	Q8N1N5
SDSLQWLPCHVGTVP	IGFN1	886	Q86VF2
PLACTSANIWPHGTS	GRIK5	331	Q16478
WVCSSLRHAQPTCPG	FASN	1546	P49327
RHCNPWPIISITNES	ERCC6L	891	Q2NKX8
AWRVSSTCFAPVHVP	OTOGL	646	Q3ZCN5
TPPCRRQHTVLWDTA	NYAP1	826	Q6ZVC0
PCVQALSHTVPVWKA	MEGF6	61	O75095
CVSTGGRPPAQITWH	PVR	166	P15151
TRAGCAHSAPQPLWT	USH2A	4136	O75445
FWDVHRPVPGCVNTT	RGS7	196	P49802
RVSWNTPQCRTLGPA	UBOX5	91	O94941
RETGTPIWTSRLPHC	SEZ6L	851	Q9BYH1
PIWTSRLPHCVSEES	SEZ6L	856	Q9BYH1
CVWHQPSGVTALTPR	SEMA4F	596	O95754
SIICVGSSWVPRIVP	LGI2	46	Q8N0V4
QLRCTTWLHPRTGEP	PLEKHA7	31	Q6IQ23
NCTAWVVSGPHCSLP	SIGIRR	31	Q6IA17
VVSGPHCSLPSVQWL	SIGIRR	36	Q6IA17
LESGHPSNLTCSVPW	SIGLEC6	156	O43699
EWPSERTGSCIPLHS	PRR32	71	B1ATL7
AWSPPTATCVALHQT	SEMA4D	521	Q92854
HCPLSGREPSQWQSR	STARD9	4041	Q9P2P6
GITCQKWSSTSPHRP	PLG	121	P00747
SAPSRIRVCQPHGVW	SNED1	731	Q8TER0
VTSTPCWIEIHLHGP	SMAD9	431	O15198
APPVTHWAASRCKAT	ACD	201	Q96AP0
CQWTRIPAPQSTTHP	PIH1D2	71	Q8WWB5
QHTSWPCGSAVPTLK	ZNF132	21	P52740
HTPVCTPTHPWTRST	SPEM3	216	A0A1B0GUW6
VTSTPCWIELHLNGP	SMAD2	431	Q15796
VAPWRSSLHPCEITA	PISD	16	Q9UG56
HTCGGSVLAPRWVVT	TMPRSS5	241	Q9H3S3
SLTCIASGWRPHEPI	TEK	41	Q02763
IHRILPPDSGVWVCS	TEK	411	Q02763
PPQRICVHSHWTVCG	MARS2	331	Q96GW9
LRCVARGSPLPHVTW	IGSF9	156	Q9P2J2
WLVPVPSPACVSNTH	ZNF469	1846	Q96JG9
AGRWGCHTRTTVLQP	TNFRSF13B	256	O14836
CNPTGPTVSCLRHWH	SCN11A	736	Q9UI33
VRHGVICFPWGLPSS	ZNF365	201	Q70YC4
CEHWVSRLPGSKPAS	USP31	786	Q70CQ4
IPWGPRHSQDSLCSS	ZNF831	956	Q5JPB2
QPRTWAAHTTACPPS	RHBDF2	61	Q6PJF5
HSCGRESVIWEITPP	THEGL	246	P0DJG4
GCGPWSQPLVVSSHD	TYRO3	401	Q06418
GVSPPLITQVHWCVL	WDR54	66	Q9H977
LHCTATGIPVPTITW	MUSK	231	O15146